Skip to content
Talquetamab
Talquetamab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target G-protein coupled receptor family C group 5 member D.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101C90.05218
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hematologic neoplasmsD019337112
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTALQUETAMAB
INNtalquetamab
Description
Talquetamab is an experimental humanized monoclonal antibody being developed by Janssen Pharmaceuticals for the treatment of multiple myeloma.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID2226212-40-2
RxCUI
ChEMBL IDCHEMBL4594503
ChEBI ID
PubChem CID
DrugBankDB16678
UNII ID4W3KFI3TN3 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
GPRC5D
GPRC5D
Organism
Homo sapiens
Gene name
GPRC5D
Gene synonyms
NCBI Gene ID
Protein name
G-protein coupled receptor family C group 5 member D
Protein synonyms
orphan G-protein coupled receptor
Uniprot ID
Mouse ortholog
Gprc5d (93746)
G-protein coupled receptor family C group 5 member D (Q9JIL6)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 115 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details